Zia Shariat-Madar

Summary

Affiliation: University of Mississippi
Country: USA

Publications

  1. ncbi request reprint Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor)
    J Wang
    Department of Pharmacology, The University of Mississippi, University, MS 38677 1848, USA
    Curr Mol Med 14:1173-85. 2014
  2. ncbi request reprint Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis
    F M Rabey
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Curr Med Chem 19:4194-206. 2012
  3. ncbi request reprint Prolylcarboxypeptidase: a cardioprotective enzyme
    J Mallela
    The School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Int J Biochem Cell Biol 41:477-81. 2009
  4. ncbi request reprint PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis
    D Kolte
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Cardiovasc Hematol Agents Med Chem 10:154-66. 2012
  5. pmc Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
    My Linh Ngo
    School of Pharmacy, Department of Pharmacology, University of Mississippi, Oxford, MS, USA
    J Inflamm (Lond) 6:3. 2009

Collaborators

  • S Diano
  • J Wang
  • D Gailani
  • D Kolte
  • F M Rabey
  • My Linh Ngo
  • J Mallela
  • D Watson
  • A Matafonov
  • A H Schmaier
  • F Mahdi
  • H Madkhali
  • J W Bryant
  • G W Gibson
  • T Tabrizian
  • Q Cheng
  • R S V S Gadepalli
  • J M Rimoldi
  • Fakhri Mahdi
  • Dhaval Kolte
  • J Yang

Detail Information

Publications6

  1. ncbi request reprint Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor)
    J Wang
    Department of Pharmacology, The University of Mississippi, University, MS 38677 1848, USA
    Curr Mol Med 14:1173-85. 2014
    ..In conclusion, PRCP1 interacts with PK at multiple sites for PK activation. PRCP1 also enhances FXIIa activation of PK, suggesting that its activation site on PK is not identical to that of FXIIa. ..
  2. ncbi request reprint Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis
    F M Rabey
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Curr Med Chem 19:4194-206. 2012
    ..UM8190 is a selective PRCP inhibitor and it may represent a new anorexigenic, and antithrombotic drug, that works by inhibiting PRCP-mediated mechanisms...
  3. ncbi request reprint Prolylcarboxypeptidase: a cardioprotective enzyme
    J Mallela
    The School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Int J Biochem Cell Biol 41:477-81. 2009
    ..The anti-hypertensive and proinflammatory properties of PRCP implicate that this enzyme may well be an accessible target for anti-inflammatory therapy...
  4. ncbi request reprint PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis
    D Kolte
    School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS 38677 1848, USA
    Cardiovasc Hematol Agents Med Chem 10:154-66. 2012
    ..Although the findings of this study indicate that PF-04886847 possesses limited anti-thrombotic and anti-inflammatory effects, PF-04886847 may have therapeutic potential in other kallikrein-kinin mediated diseases...
  5. pmc Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
    My Linh Ngo
    School of Pharmacy, Department of Pharmacology, University of Mississippi, Oxford, MS, USA
    J Inflamm (Lond) 6:3. 2009
    ....